Interestingly, an increased expression of H1.X has been found in neuroendocrine tumors (Warneboldt et al. 2008), many of which are driven by c-Myc deregulation (Farrell et al. 2017; Mollaoglu et al. 2017). Here, H1-10 is linked to neuroendocrine neoplasm.